When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
AGLE - Aeglea Bio +4.5% on updated guidance on the enrollment completion of its Phase 3 PEACE
Aeglea BioTherapeutics Inc.
Aeglea BioTherapeutics (AGLE+4.5%) updated guidance on the enrollment completion of its Phase 3 PEACE trial to evaluate the safety and efficacy of pegzilarginase in patients with Arginase 1 Deficiency given the impact of COVID-19.
More news on: Aeglea BioTherapeutics, Inc., Healthcare stocks news, Stocks on the move,